Your browser doesn't support javascript.
loading
Overcoming T790M mutant small cell lung cancer with the third-generation EGFR-TKI osimertinib.
Tang, Kejing; Jiang, Neng; Kuang, Yukun; He, Qiong; Li, Shuhua; Luo, Jiping; Jiang, Wenting; Chen, Yangshan; Sun, Yu; Chen, Lili; Chen, Yanyang; Zhu, Junfeng; Cui, Yongmei; Wan, Han; Ke, Zunfu.
Afiliação
  • Tang K; Department of Respiratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Jiang N; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Kuang Y; Department of Respiratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • He Q; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Li S; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Luo J; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Jiang W; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Chen Y; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Sun Y; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Chen L; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Chen Y; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Zhu J; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Cui Y; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Wan H; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Ke Z; Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Thorac Cancer ; 10(2): 359-364, 2019 02.
Article em En | MEDLINE | ID: mdl-30521113

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acrilamidas / Resistencia a Medicamentos Antineoplásicos / Carcinoma de Pequenas Células do Pulmão / Adenocarcinoma de Pulmão / Compostos de Anilina / Mutação Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Thorac Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acrilamidas / Resistencia a Medicamentos Antineoplásicos / Carcinoma de Pequenas Células do Pulmão / Adenocarcinoma de Pulmão / Compostos de Anilina / Mutação Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Thorac Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China